← Back to Clinical Trials
Recruiting NCT07366827

NCT07366827 Effectiveness of Motorised Lumbar Support for Non-specific Low Back Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07366827
Status Recruiting
Phase
Sponsor Laval University
Condition Non-specific Low Back Pain
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2026-02-16
Primary Completion 2027-09-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Motorized lumbar supportStandard lumbar support

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2026-02-16 with a primary completion date of 2027-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Low back pain (LBP) represents a common musculoskeletal conditions worlwide, causing substantial disability and economic burden. While traditional semi-rigid lumbar supports are commonly prescribed to alleviate LBP symptoms, their effectiveness remains limited by their static mechanical properties and lack of adaptability to movement patterns. Motorized lumbar support offer a novel approach by allowing the application of controlled decompressive forces while maintaining functional mobility. This experimental study aims to compare the effectiveness between a motorized lumbar support and a standard semi-rigid support in adults with non-specific LBP. Seventy adults with non-specific low back pain (LBP) will be recruited. Primary outcomes (pain intensity and physical functioning \[daily average\]) will be collected daily, while secondary outcomes (average pain intensity over the last week, pain-related disability, etc.) will be assessed at baseline, 3 and 9 weeks after randomization.

Eligibility Criteria

Inclusion Criteria * Adults between 18 and 65 years old with non-specific low back pain. * Average pain level of ≥3 out of 10 during the previous week. * Pain-related disability ≥10% at ODI. * Pain relief must be present during manual traction, measured by a moderate improvement (+3) on a global rating of change scale (anchors: -7 to +7). Exclusion Criteria: * Specific cause of low back pain (e.g., fracture, cancer, spinal stenosis, severe spondylolisthesis) * Presence of neuropathic pain (leg or back of 4 at the DN4). * Pregnancy. * Body mass index \> 32. * Waist size between 74 and 115 cm. * Respiratory and circulatory conditions. * Osteoporosis. * Paraplegia and hemiplegia. * Abdominal wounds at the site of the orthosis. * Rib or pelvic fractures less than 3 months. * Presence of electronic medical device.

Contact & Investigator

Central Contact

Hugo Massé-Alarie, PhD

✉ hugo.masse-alarie@fmed.ulaval.ca

📞 +1 (418) 529 9141

Principal Investigator

Hugo Massé-Alarie, PhD

PRINCIPAL INVESTIGATOR

Laval University

Frequently Asked Questions

Who can join the NCT07366827 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Non-specific Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07366827 currently recruiting?

Yes, NCT07366827 is actively recruiting participants. Contact the research team at hugo.masse-alarie@fmed.ulaval.ca for enrollment information.

Where is the NCT07366827 trial being conducted?

This trial is being conducted at Québec, Canada.

Who is sponsoring the NCT07366827 clinical trial?

NCT07366827 is sponsored by Laval University. The principal investigator is Hugo Massé-Alarie, PhD at Laval University. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology